News Search Results
Aug 05, 2025, 02:17 ET Aquaporin successfully achieves up to 20% energy savings at Kranji NEWater Factory
the United States, and China. We are committed to rethinking water filtration with biotechnology to solve global water challenges. By combining three disciplines from the world of natural sciences: biology, chemistry, and physics, we have created
More news about: Aquaporin A/S
Aug 05, 2025, 02:14 ET Aquaporin successfully achieves up to 20% energy savings at Kranji NEWater Factory
the United States, and China. We are committed to rethinking water filtration with biotechnology to solve global water challenges. By combining three disciplines from the world of natural sciences: biology, chemistry, and physics, we have created
More news about: Aquaporin A/S
Aug 04, 2025, 22:30 ET 180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy
million throughout the coming weeks in addition to continuing its prior legacy iGaming operations, as well as continuing to seek to monetize its biotechnology intellectual property. The Company plans to provide investors with regular updates on its Ethereum holdings to ensure maximum transparency.
More news about: 180 Life Sciences Corp.
Aug 04, 2025, 18:03 ET DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
than Monday, August 11, 2025. CASE ALLEGATIONS: Rocket Pharmaceuticals operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The Rocket Pharmaceuticals class action lawsuit
More news about: Robbins Geller Rudman & Dowd LLP
Aug 04, 2025, 16:05 ET INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025
MEETING, Pa., Aug. 4, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Aug 04, 2025, 16:02 ET BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPS
Conference ID: 6336054 About BioMarin BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
Aug 04, 2025, 11:00 ET Medical Device Contract Manufacturing Market to Grow at a CAGR of 11.4% from 2025 to 2032 | SkyQuest Technology Consulting
developed healthcare infrastructure and key biotechnology, and medical device companies help cement the dominance of North America in terms of global demand for medical
More news about: SkyQuest Technology
Aug 04, 2025, 10:30 ET Surgical Instrument Tracking System Market Worth US$751.2 Million by 2030 with 15.2% CAGR | MarketsandMarkets™
integrated tracking solutions. BD serves a wide range of healthcare stakeholders, including hospitals, clinical diagnostic labs, pharmaceutical and biotechnology companies, universities, and government agencies. Its robust presence is supported by a strong distribution network, combining independent channels
More news about: MarketsandMarkets
Aug 04, 2025, 10:15 ET Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 04, 2025, 10:01 ET Cell Culture Market is expected to generate a revenue of USD 93.49 Billion by 2032, Globally, at 14.23% CAGR: Verified Market Research®
ResearchVaccine ProductionToxicity TestingCell Culture Market, by End-user:Pharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesHospitals & Diagnostic LabsCell Culture Market, by Geography
More news about: Verified Market Research
Aug 04, 2025, 10:01 ET (AVAS) Acoustic Vehicle Alerting System Market Experiences 11.6% Growth Owing to Regulatory Mandates & Safety Norms | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Aug 04, 2025, 08:45 ET Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in collaboration with Cleveland Clinic, it has initiated the transfer
More news about: Anixa Biosciences, Inc.
Aug 04, 2025, 08:31 ET MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241
Aug. 4, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research collaboration with Syntekabio, Inc., a leading artificial intelligence
More news about: MetaVia Inc.
Aug 04, 2025, 08:30 ET Cresilon Announces Poster Presentation on TRAUMAGEL Case Study at the 2025 Military Health System Research Symposium
Aug. 4, 2025 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that a case study demonstrating the clinical use of its FDA-cleared hemostatic
More news about: Cresilon
Aug 04, 2025, 08:19 ET Jarlath Keating Joins as President of Solvias Group USA to Drive Growth and Innovation in Advanced Analytical Services
With nearly 30 years of experience in the biopharmaceutical and biotechnology sectors, Mr. Keating brings a robust track record of building high-performing teams, fostering customer-focused innovation, and driving commercial
More news about: Solvias
Aug 04, 2025, 08:00 ET Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
(BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.
More news about: Shilpa Medicare Limited
Aug 04, 2025, 08:00 ET Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
(BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.
More news about: Shilpa Medicare Limited
Aug 04, 2025, 08:00 ET Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche Diagnostics
Aug 04, 2025, 07:47 ET Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025
Aug. 4, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system
More news about: Intensity Therapeutics Inc.
Aug 04, 2025, 06:04 ET Tikva Allocell to Participate in Keynote Panel Discussion at Asian Pharma and Biotech Project, Program and Portfolio Management Conference
Tikva Allocell (Tikva), a biotechnology company developing off-the-shelf CAR-T cell therapies for solid tumors, today announced that its Founder and CEO, Dr. Ivan
More news about: Tikva Allocell
Aug 04, 2025, 05:33 ET MGI Tech Hands with Lincoln University to Revolutionize New Zealand Viticulture with Genomics
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Aug 04, 2025, 05:18 ET MGI Tech Hands with Lincoln University to Revolutionize New Zealand Viticulture with Genomics
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech
Aug 04, 2025, 05:09 ET Aphranel® shines in IMCAS China 2025 as Platinum Sponsor
About Aphranel Aphranel® is a high-profile medical aesthetics brand under Shanghai MOYOM Biotechnology, dedicated to advancing global aesthetics technology through cutting-edge biomaterial innovation.
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
Aug 04, 2025, 03:00 ET Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
(BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.
More news about: Shilpa Medicare Limited
Aug 04, 2025, 02:58 ET Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
advancing innovative cancer therapies and global expansion. About Anbogen Therapeutics Anbogen Therapeutics is a clinical-stage biotechnology company committed to developing precision oncology therapies that improve the lives of cancer patients worldwide. The company currently has two
More news about: Anbogen Therapeutics